MaxCyte Inc
NASDAQ:MXCT 4:00:00 PM EDT
Market Cap (Intraday) | 436.30M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $4.31 |
50-Day MA | $4.63 |
200-Day MA | $4.23 |
MaxCyte Inc Stock, NASDAQ:MXCT
9713 Key West Avenue, Suite 400, Rockville, Maryland 20850
United States of America
Phone: +1.301.944.1700
Number of Employees: 143
Description
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.